EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudie

ERCP‐Based Cell Block: A Potential One‐Stop Shop in the Management of Malignant Biliary Obstruction

Rareș Crăciun iD, Andrada Seicean, Cristina Pojoga, Roxana Popa, Bobe Petrushev, Marcel Tanțău, Cristian Tefas

Journal of Gastroenterology and Hepatology · 2025

DOI: 10.1111/jgh.70014 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Rareș Crăciun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Cholangiopancreatography, Endoscopic Retrograde, Cholestasis, Endoscopic Ultrasound-Guided Fine Needle Aspiration. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Malignant biliary obstruction (MBO) typically results from cancers like pancreatic adenocarcinoma, cholangiocarcinoma, and gallbladder carcinoma, and it often presents at an advanced stage. Diagnostic tools such as ERCP and EUS‐FNA are commonly used for tissue sampling, but each has limitations regarding accuracy and cost. This study aimed to compare the diagnostic accuracy and cost‐effectiveness of cell block (CB) cytology collected during ERCP‐guided stenting with the traditional EUS‐FNA plus ERCP‐guided stenting approach in patients with unresectable MBO.

Methods

This prospective observational study included 102 patients with advanced unresectable MBO who underwent both EUS‐FNA and ERCP‐guided stenting with CB sampling. The study evaluated the diagnostic yield of three strategies: CB alone, EUS‐FNA alone, and a combination of both methods. A cost‐effectiveness analysis was conducted using publicly available reimbursement rates from the public healthcare system to assess potential procedural cost savings.

Results

The diagnostic yield for EUS‐FNA (82.35%) was higher than for CB (72.54%), though the difference was not statistically significant ( p = 0.23). Combining both methods increased the diagnostic yield to 93.13% ( p = 0.04). CB performed better in cases with direct biliary invasion (88.23% vs. 79.41% for EUS‐FNA, p = 0.01). A cost reduction of 319.17 € per case was achieved using a CB‐only strategy in appropriate cases.

Conclusions

EUS‐FNA remains superior for diagnosing extrinsic MBO, but ERCP‐based CB offers a cost‐effective and reliable diagnostic option, particularly for biliary tract cancers. The combination of both approaches enhances diagnostic accuracy, supporting their concurrent use in specific clinical scenarios, while optimizing costs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangiopancreatography, Endoscopic RetrogradeCholestasisEndoscopic Ultrasound-Guided Fine Needle AspirationHumansProspective StudiesMaleFemaleAgedCost-Benefit AnalysisMiddle AgedStentsAged, 80 and overPancreatic NeoplasmsBile Duct Neoplasms

Stichwörter der Autor:innen

ERCPcell blockcytologyendoscopic ultrasound

Autor:innen und Institutionen

  • Department of Internal Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Department of Gastroenterology, "Prof. Dr. Octavian Fodor" Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania.
  • UBB Med, Department of Clinical Psychology and Psychotherapy, International Institute for Advanced Study of Psychotherapy and Applied Mental Health, Babeș-Bolyai University, Cluj-Napoca, Romania.
  • Department of Pathology, "Prof. Dr. Octavian Fodor" Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania.

ORCID-Profile: Rareș Crăciun

Zitieren

APA

Crăciun, R., Seicean, A., Pojoga, C., Popa, R., Petrushev, B., Tanțău, M., & Tefas, C. (2025). ERCP‐Based Cell Block: A Potential One‐Stop Shop in the Management of Malignant Biliary Obstruction. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70014

Vancouver

Crăciun R, Seicean A, Pojoga C, Popa R, Petrushev B, Tanțău M, et al. ERCP‐Based Cell Block: A Potential One‐Stop Shop in the Management of Malignant Biliary Obstruction. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.70014

BibTeX
@article{Crciun2025,
  author = {Crăciun, Rareș and Seicean, Andrada and Pojoga, Cristina and Popa, Roxana and Petrushev, Bobe and Tanțău, Marcel and Tefas, Cristian},
  title = {ERCP‐Based Cell Block: A Potential One‐Stop Shop in the Management of Malignant Biliary Obstruction},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1111/jgh.70014}
}
Kostenlos starten →